XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation Expense
6 Months Ended
Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation Expense

10. Stock-Based Compensation Expense

Total stock-based compensation expense recognized in the accompanying condensed consolidated statements of operations for the three and six months ended June 30, 2020 and 2019 was as follows (in thousands):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

RSUs and options

 

$

2,122

 

 

$

2,527

 

 

$

3,188

 

 

$

3,397

 

Employee stock purchase plan

 

 

63

 

 

 

41

 

 

 

125

 

 

 

275

 

Total stock compensation expense

 

$

2,185

 

 

$

2,568

 

 

$

3,313

 

 

$

3,672

 

 

During 2020, the Company granted the following awards:

 

 

 

Three Months Ended

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

March 31, 2020

 

 

June 30, 2020

 

 

June 30, 2020

 

Employee awards:

 

 

 

 

 

 

 

 

 

 

 

 

RSUs

 

 

230,000

 

(1)

 

2,109,228

 

(2)

 

2,339,228

 

Options

 

 

78,500

 

(3)

 

117,900

 

(4)

 

196,400

 

Non-employee director awards:

 

 

 

 

 

 

 

 

 

 

 

 

RSUs

 

 

42,067

 

(5)

 

772,685

 

(6)

 

814,752

 

Total awards:

 

 

 

 

 

 

 

 

 

 

 

 

RSUs

 

 

272,067

 

 

 

2,881,913

 

 

 

3,153,980

 

Options

 

 

78,500

 

 

 

117,900

 

 

 

196,400

 

 

(1)

RSUs had a weighted average grant date fair value of $1.25 per share and a primary vesting period of four years.  

(2)

RSUs had a weighted average grant date fair value of $1.34 per share and a primary vesting period of four years.

(3)

Options had a weighted average exercise price of $1.25 per share and vest over a four year period. The weighted average grant date fair value was $0.93 per share, as determined using a Black-Scholes option pricing model, with the following key assumptions: risk-free interest rate of 0.79%; expected life of approximately 5.67 years; volatility of 93.83%, and dividend yield of zero.

(4)

Options had a weighted average exercise price of $1.34 per share and vest over a four year period. The weighted average grant date fair value was $0.99 per share, as determined using a Black-Scholes option pricing model, with the following key assumptions: risk-free interest rate of 0.39%; expected life of approximately 5.67 years; volatility of 93.83%, and dividend yield of zero.

(5)

RSUs had a weighted average grant date fair value of $1.17 per share and vested immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service, such as resignation, retirement or death.

(6)

RSUs had a weighted average grant date fair value of $1.34 per share and vested immediately upon grant, but the underlying shares of common stock will not be delivered until there is a separation of service, such as resignation, retirement or death.

As of June 30, 2020, there was $6.8 million of unrecognized compensation expense related to options and performance options and $3.2 million of unrecognized compensation expense related to RSUs. For the options that are subject to performance conditions, the Company evaluates the probability that the performance conditions will be met and estimates the service period for recognition of the associated expense.